New Key Statistics Module, Z-Score and F-Score
SHSE:600332 Key Ratios
Market Cap ¥ M | 49,050.25 |
Enterprise Value ¥ M | 43,095.39 |
P/E(ttm) | 12.55 |
PE Ratio without NRI | 12.42 |
Forward PE Ratio | -- |
Price/Book | 1.40 |
Price/Sales | 0.67 |
Price/Free Cash Flow | 24.59 |
Price/Owner Earnings | 19.41 |
Payout Ratio % | 0.29 |
Revenue (TTM) ¥ M | 76,833.00 |
EPS (TTM) ¥ | 2.52 |
Beneish M-Score | -2.33 |
10-y EBITDA Growth Rate % | 14.70 |
5-y EBITDA Growth Rate % | 8.50 |
y-y EBITDA Growth Rate % | 1.30 |
EV-to-EBIT | 7.63 |
EV-to-EBITDA | 7.63 |
PEG | 1.46 |
Shares Outstanding M | 1,625.79 |
Net Margin (%) | 5.34 |
Operating Margin % | 6.47 |
Pre-tax Margin (%) | 6.78 |
Quick Ratio | 1.35 |
Current Ratio | 1.64 |
ROA % (ttm) | 5.42 |
ROE % (ttm) | 11.79 |
ROIC % (ttm) | 12.25 |
Dividend Yield % | 2.31 |
Altman Z-Score | 2.69 |
SHSE:600332 Number of Guru Trades
SHSE:600332 Volume of Guru Trades
Gurus Latest Trades with SHSE:600332
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:600332 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Insider Transactions
No Available Data